Calibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio

Summary

Thromboplastins vary in their sensitivity to the haemostatic defect induced by oral anticoagulants. To provide a means of standardising prothrombin time tests, the World Health Organization adopted in 1977 a scheme for calibrating thromboplastins in terms of an International Reference Preparation. Unfortunately, the model on which this scheme was based does not always hold. A revised calibration model has therefore been developed and this has been tested in a recent collaborative study. The revised model, which retains fundamentally the same principle for standardising prothrombin time tests, has proved suitable for calibrating thromboplastins of different species and types and, moreover, has certain statistical advantages over its predecessor. In September 1982, the WHO Expert Committee on Biological Standardization adopted the revised model. This paper explains the nature and rationale of this change and considers its practical implications.

Keywords

Thromboplastin - Prothrombin time - Standardisation

• References

• 1 Zucker S, Brosious E, Cooper GR. One-stage prothrombin time survey. Am J Clin Pathol 1970; 53: 340-347
• 2 ICTH/ICSH. Prothrombin time standardization: report of the expert panel on oral anticoagulant control. Thromb Haemostas 1979; 42: 1073-1114
• 3 Biggs R, Denson KW. Standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Br Med J 1967; 1: 84-88
• 4 Poller L. A national standard for anticoagulant therapy. The Manchester comparative reagent. Lancet 1967; 1: 491-493
• 5 WHO Expert Committee on Biological Standardization. 28th Report. WHO Tech Rep Ser 1977; 610 14-15 and 45-51
• 6 WHO Expert Committee on Biological Standardization. 31st Report. WHO Tech Rep Ser 1981; 658: 185-205
• 7 Bangham DR, Biggs R, Brozovic M, Denson KW. Calibration of five different thromboplastins, using fresh and freeze-dried plasma. Thrombos Diathes Haemorrh 1973; 29: 228-239
• 8 Loeliger EA, Besselaar AM, van HP, Benina RM. Critical appraisal, clinical usefulness and implementation of the thromboplastin concept of prothrombin-time standardization. In: Standardization and Quality Control of Coagulation Tests. Mannucci PM, Mariani G, Tentori L. (Eds) Scand J Haematol. 1980. 25. (Supp137) 34-48
• 9 Loeliger EA, Besselaar AM, van HP, Hermans J, Velde EA van der. Certification of Three Reference Materials for Thromboplastins BCR Information, Commission of the European Communities, Brussels. 1981
• 10 Loeliger EA, Hoeff-van Halem Rvan der, Halem-Visser LP van. Thromboplastin calibration. Experience of the Dutch Reference Laboratory for Anticoagulant Control. Thromb Haemostas 1978; 40: 272-287
• 11 Besselaar AM H P van den, Halem-Visser LP van, Hoekstra-Schurnan L, Marel-van Nieuwkoop Wvan der, Loeliger EA. Simplified thromboplastin calibration. Further experience of the Dutch Reference Laboratory for Anticoagulant Control. Thromb Haemostas 1980; 43: 53-57
• 12 Alderson MR, Poller L, Thomson JM. Validity of the British system for anticoagulant control using the national reagent. J Clin Pathol 1970; 23: 281-285
• 13 Kahan J, Noren I. Assessment of different mathematical models for calculating and expressing the results of coagulation test procedures. Thrombos Diathes Haemorrh 1975; 34: 522-530
• 14 Exner T, Rickard KA, Kronenberg H. Comparison of thromboplastin used for oral anticoagulant control. Pathology 1980; 12: 559-566
• 15 Murphy EA, Denson KW. Statistical analysis of experiments performed in connection with thromboplastin standardisation Fibrinogen: Structural, metabolic and pathophysiologic aspects. Owren PA, Brinkhous KM, Wright IS, Roberts HR, Hinnom S, Kiesselbach TH. (Eds). Proceedings of the International Committee on Thrombosis and Haemostasis, Princeton, NY, USA. Schattauer, Stuttgart. 1968; pp 377-395
• 16 WHO Expert Committee on Biological Standardization. 33rd Report.WHO Tech Rep. in press.
• 17 Combleet PJ, Gochman N. Incorrect least-squares regression coefficients in method-comparison analysis. Clin Chem 1979; 25: 432-438
• 18 Armitage P. Statistical Methods in Medical Research. Blackwell Scientific Publications; Oxford: 1971
• 19 Kendall MG, Stuart A. The Advanced Theory of Statistics, Charles Griffin. London 1967; 2: 375-418
• 20 Poller L, Thomson JM, Yee KF. Stability studies on lyophilised reference thromboplastins for standardisation of prothrombin-times. Lancet 1977; 2: 1019-1022
• 21 Bangham DR, Loeliger EA. Stability of reference thromboplastins. Lancet 1977; 2: 1280-1281
• 22 Besselaar AM, Van HP, Halem-Visser LP van, Loeliger EA, Hermans J. Stability of international reference thromboplastins. Br J Haematol 1980; 45: 153-160
• 23 Jeme NK, Perry WL. The stability of biological standards. Bull WHO 1956; 14: 167-182
• 24 Kirkwood TB. Predicting the stability of biological standards and products. Biometrics 1977; 33: 736-742
• 25 Evatt BL, Brogan D, Triplett D, Koepke J, Waters G. Effect of thromboplastin and instrumentation on the prothrombin time test. Clin Lab Haematol 1981; 3: 331-342
• 26 Gralnick HR, Evatt BL, Huseby RM, Triplett DA. Procedural standards for the prothrombin time. In: Standardization of Coagulation Assays: An Overview. Triplett DA. (Ed) College of American Pathologists; Skokie: 1982. pp 51-55